Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 12NIH 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2Dermatologic 1

Conditions

Brain Neoplasms 2Neoplasm Metastasis 1Melanoma 1Glioblastoma 1Carcinoma 1

Interventions

Cyclophosphamide 385Specimen Handling 371Magnetic Resonance Spectroscopy 325Radiotherapy 306Biopsy 269Cisplatin 257Carboplatin 253Paclitaxel 235Doxorubicin 226Fluorouracil 200Etoposide 197Vincristine 182Bevacizumab 180Filgrastim 170Gemcitabine 163Leucovorin 149Cytarabine 144aldesleukin 140Taxes 127Docetaxel 122Oxaliplatin 113Chemotherapy, Adjuvant 113fludarabine phosphate 111Rituximab 107Methotrexate 107Radiation 106Bortezomib 105Prednisone 102Irinotecan 100Dexamethasone 100

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Interventional × Craniotomy × Clear all
NCT01413438 2017-07-02

Bevacizumab With or Without Surgery for Adult Glioblastomas

National Institutes of Health Clinical Center (CC)

Phase 2 Withdrawn
CNS

Brain Neoplasms, Glioblastoma

NCT00075166 2008-03-04

Surgery Versus Radiosurgery to Treat Metastatic Brain Tumors

National Institutes of Health Clinical Center (CC)

Phase 4 Completed
130 enrolled
CNSDermatologic

Brain Neoplasms, Carcinoma, Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡